Physician profile
Robert Maxwell
NPI 1982698627
$7,378.16
in general payments reported to CMS, 2019-2025
22 companies · $1,338 in 2025
The $1,338 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $317 · 2021: $114 · 2022: $1,464 · 2023: $1,780 · 2024: $2,025 · 2025: $1,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,182 · Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,182.20 |
| Food and Beverage | $960.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $1,724.88 | 2023 | |
| Steris Corporation | $1,673.69 | 2024 | |
| Intuitive Surgical, INC. | $1,421.25 | 2019-2025 | |
| Medical Device Business Services, INC. | $1,087.98 | 2022 | |
| Ethicon US, LLC | $478.37 | 2019-2024 | Prolene, Evarrest, Echelon Endopath |
| Smith+Nephew, INC. | $240.11 | 2022-2024 | Renasys Touch, Oasis, Stravix |
| Haemonetics Corporation | $133.27 | 2020-2024 | Teg6s Hemostasis System |
| Tela Bio, INC. | $91.63 | 2019 | |
| Prytime Medical Devices, INC. | $89.73 | 2019-2024 | Er-Reboa Plus |
| Medtronic, INC. | $87.49 | 2022-2025 | Signia |
| Olympus America INC. | $48.46 | 2025 | |
| Merck Sharp & Dohme LLC | $45.83 | 2019-2025 | Zerbaxa |
| Edwards Lifesciences Corporation | $38.18 | 2024 | Hemosphere |
| Baxter Healthcare | $37.85 | 2024 | Renal - Acute |
| Acera Surgical, INC. | $28.19 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $25.65 | 2025 | Arista |
| Teleflex LLC | $25.51 | 2025 | Quikclot |
| Zimmer Biomet Holdings, INC. | $25.42 | 2025 | Ribfix Blu Advantage, Ribfix Titan |
| Atricure, INC. | $21.20 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| La Jolla Pharmaceutical Company | $20.98 | 2025 | Giapreza |
| Hemosonics LLC | $18.20 | 2020 | |
| Covidien Lp | $14.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Maxwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.